APA (7th ed.) Citation

B, C., S, N., JO, A., B, W., C, N., AC, G., . . . CL, B. (2019). Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. The oncologist, 24(4), 537. https://doi.org/10.1634/theoncologist.2018-0341

Chicago Style (17th ed.) Citation

B, Chen, et al. "Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada." The Oncologist 24, no. 4 (2019): 537. https://doi.org/10.1634/theoncologist.2018-0341.

MLA (9th ed.) Citation

B, Chen, et al. "Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada." The Oncologist, vol. 24, no. 4, 2019, p. 537, https://doi.org/10.1634/theoncologist.2018-0341.